Press Release: Glenveigh Medical : Research and Markets: Pre-Eclampsia Pipeline Review, H2 2015 Edition Featuring A1M Pharma AB, Alnylam Pharmaceuticals, Glenveigh Medical, Pluristem Therapeutics, rEVO Biologics & VG Life Sciences

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pbms42/preeclampsia) has announced the addition of the "Pre-Eclampsia - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest